Daniel Weintraub

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

6.0Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease

Movement Disorders(2021)10.1002/mds.28706

Top 8%

2.8DataRank

Top 8%140 citations

Joanna K. Bright, Sarah Al–Bachari, Tim Anderson, Tyler Ard, Francesca Assogna +42 more

Papers

Driven by 64 papers — median percentile 75. Top paper: “International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease”.

International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease

Movement Disorders(2021)10.1002/mds.28706

Top 8%

2.8DataRank

Top 8%140 citations

Joanna K. Bright, Sarah Al–Bachari, Tim Anderson, Tyler Ard, Francesca Assogna +42 more

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433

Top 12%

1.7DataRank

Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

npj Parkinson s Disease(2024)10.1038/s41531-024-00789-w

Top 25%

0.813DataRank

Top 25%37 citations

Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub +95 more

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

The Lancet Neurology(2015)10.1016/s1474-4422(15)00178-7

N/A

0.811DataRank · unranked

222 citations

Cory Y. McLean, Jacqueline Rick, Shirley Eberly, Samantha J. Hutten, Katrina Gwinn +40 more

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Movement Disorders(2020)10.1002/mds.28206

N/A

0.798DataRank · unranked

204 citations

Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg +21 more

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

UNC Libraries(2020)10.17615/mfr2-9e14

N/A

0.781DataRank · unranked

181 citations

Alexander I. Tröster, Ben Schmand, Jaime Kulisevsky, Caroline H. Williams‐Gray, Roger A. Barker +11 more

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

Movement Disorders(2021)10.1002/mds.28779

N/A

0.777DataRank · unranked

177 citations

Teresa Waligórska, Junchao Shen, Thomas F. Tropea, Andrew Siderowf, Daniel Weintraub +8 more

Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

Movement Disorders Clinical Practice(2023)10.1002/mdc3.13751

N/A

0.688DataRank · unranked

11 citations

Marina Picillo, Hyunkeun Ryan Cho, Chelsea Caspell‐Garcia, Cornelis Blauwendraat, Ethan Brown +17 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699

N/A

0.654DataRank · unranked

77 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14145

Top 31%

0.648DataRank

Top 31%11 citations

Roseanne D. Dobkin, Daniel Weintraub, Hyunkeun R. Cho, Chelsea Caspell‐Garcia, Meredith Bock +4 more

Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus

Movement Disorders(2024)10.1002/mds.29700

N/A

0.624DataRank · unranked

63 citations

Steffen Paschen, Deborah Amstutz, Francisco Cardoso, Jean‐Christophe Corvol, Victor S.C. Fung +8 more

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

Alzheimer s & Dementia(2021)10.1002/alz.12480

N/A

0.578DataRank · unranked

46 citations

Zeynep Demir, Dallas P. Veitch, Daniel Weintraub, Paul Aisen, Clifford R. Jack +8 more

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting

npj Parkinson s Disease(2022)10.1038/s41531-022-00330-x

N/A

0.574DataRank · unranked

45 citations

Marlene Pils, Victoria Kraemer‐Schulien, Alexandra Dybala, Anja Schaffrath, Andreas Kulawik +17 more

What's in a Name? The Time Has Come to Unify Parkinson's Disease and Dementia with Lewy Bodies

Movement Disorders(2023)10.1002/mds.29590

N/A

0.515DataRank · unranked

30 citations

Daniel Weintraub

Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease

Movement Disorders(2021)10.1002/mds.28886

N/A

0.470DataRank · unranked

22 citations

Daniel Sirica, Duygu Tosun, Robert Zivadinov, Ofer Pasternak, Daniel Weintraub +3 more

Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease

Movement Disorders(2024)10.1002/mds.29725

N/A

0.385DataRank · unranked

12 citations

Connie Marras, Amy W. Amara, Karen E. Anderson, Lana M. Chahine, Shirley Eberly +10 more

A worldwide study of subcortical shape as a marker for clinical staging in Parkinson’s disease

npj Parkinson s Disease(2024)10.1038/s41531-024-00825-9

N/A

0.385DataRank · unranked

12 citations

Yuji Zhao, Eva M. van Heese, Joanna K. Bright, Conor Owens‐Walton, Sarah Al–Bachari +48 more

A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14305

N/A

0.360DataRank · unranked

10 citations

Irene Litvan, Daniel Weintraub, Jennifer G. Goldman, Alexander I. Tröster, Simon J.G. Lewis +2 more

Posterior hippocampal sparing in Lewy body disorders with Alzheimer’s copathology: An in vivo MRI study

NeuroImage Clinical(2024)10.1016/j.nicl.2024.103714

N/A

0.312DataRank · unranked

7 citations

Jeffrey Phillips, Sandhitsu R. Das, Christopher A. Olm, Hamsanandini Radhakrishnan, Emma Rhodes +10 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1

N/A

0.104DataRank · unranked

1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial

Parkinsonism & Related Disorders(2023)10.1016/j.parkreldis.2023.105951

N/A

0DataRank · unranked

16 citations

Alberto J. Espay, Vibhash D. Sharma, Pierre N. Tariot, Victor Abler, Sanjeev Pathak +2 more

Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease

Parkinsonism & Related Disorders(2023)10.1016/j.parkreldis.2023.105822

N/A

0DataRank · unranked

8 citations

Thanh Phuong Pham Nguyen, Craig Newcomb, Shelly L. Gray, Sean Hennessy, Charles E. Leonard +4 more

Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies

Neurotherapeutics(2023)10.1007/s13311-023-01344-w

N/A

0DataRank · unranked

1 citations

Thanh Phuong Pham Nguyen, Leah J. Blank, Dylan Thibault, Shelly L. Gray, Sean Hennessy +4 more

Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury

Parkinsonism & Related Disorders(2023)10.1016/j.parkreldis.2023.105793

N/A

0DataRank · unranked

3 citations

Shelly L. Gray, Craig Newcomb, Qing Liu, Ali G. Hamedani, Daniel Weintraub +3 more

Internal tremor in people with Parkinson’s Disease: Demographic characteristics and comorbid symptoms

Clinical Parkinsonism & Related Disorders(2023)10.1016/j.prdoa.2023.100229

N/A

0DataRank · unranked

0 citations

Lakshmi Arbatti, Abhishek Hosamath, Amy W. Amara, Karen E. Anderson, Jennifer L. Purks +10 more

Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000208033

N/A

0DataRank · unranked

23 citations

David J. Irwin, Thomas F. Tropea, Emma Rhodes, Jeffrey S. Phillips, Alice S. Chen-Plotkin +18 more

Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level

npj Parkinson s Disease(2024)10.1038/s41531-024-00690-6

N/A

0DataRank · unranked

11 citations

Whitney Hartstone, Noor Amari, Dylan Baum, Jacqueline Rick, Eunran Suh +23 more

Improving Parkinson's Disease Care through Systematic Screening for Depression

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14163

N/A

0DataRank · unranked

10 citations

Zachary Meyer, Hongliang Liu, Sheng Luo, Sneha Mantri, Allison Allen +18 more

Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14089

N/A

0DataRank · unranked

6 citations

Daniel Weintraub, Tanya Simuni, Mayela Rodríguez‐Violante, Albert F.G. Leentjens, Joshua Shulman +8 more

GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders

Movement Disorders(2024)10.1002/mds.29773

N/A

0DataRank · unranked

4 citations

Yunji Seo, Eunran Suh, Noor Amari, Whitney Hartstone, R. Tyler Skrinak +7 more

Alzheimer’s disease neuropathologic change mediates the relationship between ambient air pollution and dementia severity

medRxiv(2024)10.1101/2024.07.18.24310646

N/A

0DataRank · unranked

1 citations

Kaitlin Blam, Holly Elser, Sharon X. Xie, Vivianna M. Van Deerlin, T.M. Penning +8 more

Parkinson’s Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype?

Research Square(2024)10.21203/rs.3.rs-5278177/v1

N/A

0DataRank · unranked

1 citations

Hiba Vohra, Sarah K. Lageman, Nitai D. Mukhopadhyay, Brian Berman, Daniel Weintraub +2 more

Microstructural changes in the inferior tuberal hypothalamus correlate with daytime sleepiness in Lewy body disease

medRxiv(2024)10.1101/2024.08.16.24312102

N/A

0DataRank · unranked

0 citations

Hamsanandini Radhakrishnan, Christopher A. Olm, Sandhitsu R. Das, Philip A. Cook, David A. Wolk +4 more

Alpha-Synuclein Conformations in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies

Research Square(2024)10.21203/rs.3.rs-5033901/v1

N/A

0DataRank · unranked

0 citations

George T. Kannarkat, Rebecca Zack, R. Tyler Skrinak, James F. Morley, Roseanne Davila‐Rivera +13 more

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia

medRxiv(2024)10.1101/2024.12.12.24318917

N/A

0DataRank · unranked

0 citations

Anuprita R Nair, Ryan Kurth, Michael C. Brumm, Michele K. York, Roseanne D. Dobkin +20 more

Neuronal alpha-Synuclein Disease stage progression over five years

medRxiv(2024)10.1101/2024.12.17.24319172

Top 100%

0DataRank

Top 100%0 citations

Caroline Gochanour, Anuprita R Nair, Michael C. Brumm, Christopher S. Coffey, Kathleen L. Poston +14 more

Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease

Brain Communications(2025)10.1093/braincomms/fcaf146

N/A

0DataRank · unranked

9 citations

Cameron Shand, Beatrice Taylor, Henk W. Berendse, Chris Vriend, Tim D. van Balkom +67 more

Validation of the International Parkinson and Movement Disorder Society Non‐Motor Symptoms Questionnaire (MDS‐NMS‐Q)

Movement Disorders(2025)10.1002/mds.30202

N/A

0DataRank · unranked

6 citations

К. Ray Chaudhuri, Anette Schrag, Pablo Martínez‐Martín, Alexandra Rizos, Eugenia Mamikonyan +6 more

Blood α‐Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies

Annals of Neurology(2025)10.1002/ana.27288

N/A

0DataRank · unranked

4 citations

Rebecca Zack, R. Tyler Skrinak, James F. Morley, Roseanne Davila‐Rivera, Sanaz Arezoumandan +13 more

Reply to: “Refutation of the αSyn ‐ SAA ‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD ‐ ISS] )”

Movement Disorders(2025)10.1002/mds.30272

N/A

0DataRank · unranked

1 citations

Lana M. Chahine, Kathleen L. Poston, Catherine Kopil, Daniel Weintraub, Billy Dunn +2 more

Clinical and imaging characteristics of Parkinson’s disease with negative alpha-synuclein seed amplification assay

medRxiv(2025)10.1101/2025.10.01.25337085

N/A

0DataRank · unranked

1 citations

Jacopo Pasquini, Seung Ho Choi, David-Erick Lafontant, Seyed‐Mohammad Fereshtehnejad, Yashar Zeighami +25 more

Microstructural Changes in the Tuberal Hypothalamus Correlate with Daytime Sleepiness in Lewy Body Disorders

Movement Disorders(2025)10.1002/mds.30244

N/A

0DataRank · unranked

0 citations

Hamsanandini Radhakrishnan, Christopher A. Olm, Sandhitsu R. Das, Philip A. Cook, S. J. Wolk +4 more

The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?

Movement Disorders(2025)10.1002/mds.30295

N/A

0DataRank · unranked

0 citations

Izabelle Schoen, Daniel Weintraub

Utilizing Intraindividual Cognitive Variability to Predict Early Neuronal Synuclein Disease Progression

medRxiv(2025)10.1101/2025.10.21.25338482

N/A

0DataRank · unranked

0 citations

Ryan Kurth, Anuprita Nair, Michele K. York, Daniel Weintraub, David-Erick Lafontant +3 more

Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example

Movement Disorders(2025)10.1002/mds.30111

N/A

0DataRank · unranked

8 citations

Michael C. Brumm, Ryan Kurth, Michele K. York, the Parkinson's Progression Markers Initiative, Daniel Weintraub

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Annals of Neurology(2020)10.1002/ana.25811

N/A

0DataRank · unranked

111 citations

Janel Fedler, Christopher S. Coffey, Chelsea Caspell‐Garcia, Ju‐Hee Kang, Tanya Simuni +16 more

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Movement Disorders(2020)10.1002/mds.28312

N/A

0DataRank · unranked

102 citations

Cornelis Blauwendraat, Hampton L. Leonard, Mary B. Makarious, Jonggeol J. Kim, Ganqiang Liu +43 more

Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease

Age and Ageing(2020)10.1093/ageing/afaa033

N/A

0DataRank · unranked

27 citations

Thanh Phuong Pham Nguyen, Sean Hennessy, Daniel Weintraub, Shelly L. Gray, Dawei Xie +2 more

Multimodal in vivo and postmortem assessments of tau in Lewy body disorders

Neurobiology of Aging(2020)10.1016/j.neurobiolaging.2020.08.003

N/A

0DataRank · unranked

23 citations

Jeffrey S. Phillips, Emily Roll, Claire Peterson, Rebecca Lobrovich, Katya Rascovsky +13 more

Clinical Follow‐up of Parkinson's Disease With Newly Prescribed Quetiapine

Movement Disorders(2020)10.1002/mds.28193

N/A

0DataRank · unranked

1 citations

Claire Chiang, Hyungjin Myra Kim, Jayne Wilkinson, Connie Marras, Barbara Stanislawski +3 more

ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s Disease and Dementia with Lewy Bodies

medRxiv(2020)10.1101/2020.04.07.20056614

N/A

0DataRank · unranked

1 citations

Thomas F. Tropea, John Robinson, Eunran Suh, Howard I. Hurtig, Daniel Weintraub +5 more

Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations

Journal of Parkinson s Disease(2021)10.3233/jpd-202472

N/A

0DataRank · unranked

136 citations

Seyed-Mohammad Fereshtehnejad, Daniela Berg, Nicolaas I. Bohnen, Kathy Dujardin, Roberto Erro +19 more

Management of psychiatric and cognitive complications in Parkinson’s disease

BMJ(2022)10.1136/bmj-2021-068718

N/A

0DataRank · unranked

85 citations

Dag Aarsland, Roberta Biundo, Roseanne D. Dobkin, Jennifer G. Goldman, Simon J.G. Lewis +1 more

Genetic prediction of impulse control disorders in Parkinson's disease

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51569

N/A

0DataRank · unranked

37 citations

Marijan Posavi, Pierre Fontanillas, Thomas F. Tropea, Eugenia Mamikonyan, Eunran Suh +5 more

Plasma phosphorylated tau181 predicts cognitive and functional decline

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51695

N/A

0DataRank · unranked

34 citations

Teresa Waligórska, Sharon X. Xie, Ilya M. Nasrallah, Katheryn A Q Cousins, John Q. Trojanowski +9 more

Plasma MIA , CRP , and Albumin Predict Cognitive Decline in Parkinson's Disease

Annals of Neurology(2022)10.1002/ana.26410

N/A

0DataRank · unranked

33 citations

Noor Amari, Rebecca Zack, R. Tyler Skrinak, Travis L. Unger, Marijan Posavi +8 more

Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias

Parkinsonism & Related Disorders(2022)10.1016/j.parkreldis.2022.07.023

N/A

0DataRank · unranked

14 citations

Sunghye Cho, Katheryn A Q Cousins, Mark Liberman, Erica Howard, Yvonne Balganorth +10 more

Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers

Parkinsonism & Related Disorders(2022)10.1016/j.parkreldis.2022.05.022

N/A

0DataRank · unranked

11 citations

Katheryn A Q Cousins, Andrew Siderowf, John E. Duda, James F. Morley, Nabila Dahodwala +11 more

Atypical antipsychotic use and mortality risk in Parkinson disease

Parkinsonism & Related Disorders(2022)10.1016/j.parkreldis.2022.08.013

N/A

0DataRank · unranked

8 citations

Dylan Thibault, Ali G. Hamedani, Daniel Weintraub, Allison W. Willis, Thanh Phuong Pham Nguyen

Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s Disease

medRxiv(2022)10.1101/2022.03.16.22272456

N/A

0DataRank · unranked

2 citations

Noor Amari, Rebecca Zack, R. Tyler Skrinak, Travis L. Unger, Marijan Posavi +8 more

Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Movement Disorders(2023)10.1002/mds.29410

N/A

0DataRank · unranked

357 citations

Marie‐Ann Kaldenbach, Angelo Antonini, Pablo Martínez‐Martín, Lars Timmermann, Per Odin +24 more

Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated

Brain(2023)10.1093/brain/awad059

N/A

0DataRank · unranked

171 citations

Sharon X. Xie, Daniel R. Baer, Eunran Suh, Vivianna M. Van Deerlin, Nicholas Loh +10 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2

N/A

0DataRank · unranked

42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more

Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications

Movement Disorders Clinical Practice(2023)10.1002/mdc3.13738

N/A

0DataRank · unranked

19 citations

I.‐I. Lin, Eugenia Mamikonyan, Wissam Deeb, Robert Feldman, Andrew D. Althouse +7 more

Daniel Weintraub

Indexed papers

Top data-sharing exemplar

Papers